Alliance Global Partners Downgrades Capricor Therapeutics (CAPR) to Neutral
Alliance Global Partners analyst Matt Venezia downgraded Capricor Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
